Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of treatments for apomorphine-induced skin reactions
NL-OMON41221Phase 2Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of apomorphine and hydrocortisone in Parkinson's disease (PD), sponsored by University Medical Center Groningen. Primary endpoint: Absolute change on global perceived effect scale. Started Oct 2015; status: active, not recruiting.
02
Drugs
apomorphinehydrocortisone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON41221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41221.